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Abstract
The metal-binding abilities of a wide variety of bioactive aminophosphonates, from the
simple aminoethanephosphonic acids to the rather large macrocyclic polyaza derivatives, are
discussed with special emphasis on a comparison of the analogous carboxylic acid and
phosphonic acid systems. Examples are given of the biological importance of metal
ion- aminophosphonate interactions in living systems, and also of their actual and potential
applicability in medicine.
Aminophosphonic acids are broadly defined as analogues of aminocarboxylates (including
polyamino and/or polycarboxylates)in which one or more carboxylic group(s) are replaced by
phosphonic or related functions (phosphonous, phosphinic, etc.). A common characteristic
of these compounds, in contrast to the organic phosphates, is that they all contain a carbon-
to-phosphorus bond. They were first synthetized in the forties and were found to occur in
living organisms in the late fifties. Only a few of them [e.g. 2-aminoethanephosphonic acid
(/Y-AlaP), or 2-amino-3-phosphonopropionic acid (Asp-/YP)] are found as free compounds in
tissues, whereas they usually occur in bound forms as phosphonopeptides, phosphonolipids
and phosphonoglycolipids.
The discovery of aminophosphonates in living systems stimulated the interest in this group
of compounds and the intensive research directed towards synthesis of phosphonic acid
analogues of protein and non-protein amino acids resulted in a new class of drugs and other
bioactive compounds with a great variety of commercial applications ranging from agriculture
to medicine. Consequently, studies on aminophosphonates accelerated significantly in the
past twenty years, when it was revealed that many of the synthetic aminophosphonic acids
display diverse and useful biological properties. Thus, this class of compounds include
promising anticancer agents, strong neuromodulators, plant growth regulators and herbicides,
antibacterial phosphono peptides, metal-sequestering drugs, radiopharmaceuticals and NMR
imaging agents. 1-7
What are therefore the properties of this ligand class which make them able to exert such
versatile biological activity? Firstly, being structural analogues of amino acids,
aminophosphonic acids can act as their antimetabolites and compete with their carboxylic
counterparts for the active sites of enzymes (including metalloenzymes) and other cellular
receptors. As inhibitors of metabolic processes they can exert the above-mentioned
physiological activity. Secondly, aminopolyphosphonates and polyaminopolyphosphonates,
including open-chain and cyclic derivatives, containing strong metal binding donors are able
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to chelate essential or toxic metal ions strongly enough either to compete with
metalloenzymes or other metalloreceptors, or to remove toxic metal ions from living systems,
or to ensure their uptake by the organism e.go for diagnostic, or therapeutic purposes. In any
cases their interactions with metal ions may be of fundamental. These features comprise the
scope of this paper with special emphasis on a comparison of the chelating properties of the
analogous carboxylic and phosphonic compounds.
Carboxylic and phosphonic groups differ substantially in many respects, including size (the
phosphonic function is considerably larger), shape (flat carboxylate and tetrahedral
phosphonate), basicity (phosphonate is more basic than carboxylate) and charge
(phosphonate is binegative, while carboxylate is mononegative).
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Figure 1. Structural formulas of aminocarboxylates and their phosphono derivatives (the pK
range of the donor groups are given in parenthesis).
A comparison of the acid- base characters of simple e-aminocarboxylates and their various
phosphoric derivatives (see Figure 1) demonstrates that the pK of the acid-OH increases in
the sequence phosphonous [-PO(H)(OH)] phosphinic [-PO(R)(OH)] < carboxylic
[-CO(OH)] < phosphonic [-PO2(OH)-] phosphoric [-OPO2(OH)-]. The first proton of
the phosphonic and phosphoric acid derivatives is very acidic and, similarly as in the
phosphonous and phosphinic acids, pK 1. The acidity sequence of the ammonium group
of these ligands corresponds to the variations in the electron-withdrawing effects of the other
2- 2 group; this gives the following trend: PO3 < OPO3 < CO2 < PO2R < PO2H
Similarly as for the e-amino-carboxylate analogues, the presence of a cyclic conformation
involving internal hydrogen-bonding between the phosphonate and ammonium groups in the
zwitterionic form is strongly supported by the results of NMR studies. 8
As concerns the metal-binding abilities of these phosphono derivatives, bidentate (N,O)-
chelation is of greatest importance for most of the biologically important transition metal ions.
Because of the relatively high basicity of the PO:
2" group, there is also a possibility for
modentate coordination of the phosphonate group in acidic solution. In alkaline solution,
monodentate NH2-coordination too can occur, e.g. with cis-Pt(NH)
2+ 9-10 The sequence
of stability of the (N,O)-chelated complexes corresponds roughly to the overall basicity
sequence of the coordinating donor groups; the higher the basicity of the donor groups the
higher the stability of the complexes formed. To illustrate this, the metal complex formation
constants of the different phosphono derivatives of alanine (Ala) are compiled in Table I.
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Table I. Overall stability constants and basicity adjusted stability constantsa of the metal
complexes of some aminocarboxylic acids and their phosphonic and phosphinic
derivatives at 1=0.20 mol dm"3 (KCI) and t 25 C
Metal Ligand IOgKMA IOgKMA2 IOgKMA IOgKMA2
Cu(ll) e-Ala 8.04 6.69 -3.99 -5.34
e-AlaP 8.29 6.65 -7.37 -9.01
e’-AlaPo 4.87 4.04 -4.16 -4.99
a-Ala Pi 5.45 4.54 -3.84 -4.75
Ni(ll) e-Ala 5.32 4.42 -6.71 -7.61
e-AlaP 5.42 3.89 -10.24 -11.77
Co(I I) a-Ala 4.24 3.41 -7.79 -8.62
a-AlaP 4.55 3.15 -11.11 -12.51
Zn(ll) a-Ala 4.56 3.95 -7.67 -7.06
e-AlaP 5.99 -9.67
Cu(ll) #-Ala 6.91 5.45 -6.65 -8.11
/Y-AlaP 8.53 6.43 -8.60 -10.70
Co(ll) #-Ala 3.49 2.59 10.07 10.97
/Y-AlaP 5.16 3.66 -11.97 -13.47
Ni(ll) #-Ala 4.52 3.32 -9.04 -10.24
/Y-AlaP 5.34 3.70 -11.79 -13.42
Zn(ll) /9-Ala 3.78 3.12 -9.78 -10.44
/Y-AlaP 6.09 4.85 -11.04 -12.28
a Values are obtained from Ref. 43, 44; IOgKMA =IogKMA-’pK, characteristic for the proton
displacement reaction M2 + + HnA MA + nil+; IOgKMA2"= IOgKMA -lpK, characteristic
for the reaction MA + HnA MA2 + nH +. 2
The equilibrium constants characteristic of the reaction M2 + + H2A MA + 2 H +, which
express the competition between proton and metal ion for the ligand chelating site, may be
a more realistic measure of the relative metal ion-binding strength. These basicity-adjusted
stability constants for the aminophosphinate complexes (AlaPo and AlaPi) are about the same
as those of the Ala complexes, but much larger than those of the AlaP complexes. That is,
the lower overall stability of the phosphonous and phosphinic complexes is due purely to the
lower basicity of the donor groups (cf. PKpo_(oH)- for the aminophosphonic acid and
2 PKpo(R)(OH for the aminophosphonous and aminophosphinic acids, which are 5.5 and 1.0,
respectively). However, for aminophosphonates the electrostatic and steric hindrance due to
the binegative charge and the larger size of the P032- group significantly overcompensates
the stability increase arising from the higher basicity of the phosphonate group, and the
proton displacement constants are 2-3 orders of magnitude lower than those for the metal
complexes of the aminocarboxylate analogue, Ala. 11 It can also be seen from these basicity-
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adjusted stability constants that the metal-binding abilities of aminophosphonates and
aminocarboxylates forming five- or six-membered chelate rings follow the sequence
5(NH2,CO2-) > 6(NH2,CO2-).- 5(NH2,PO32-) > 6(NH2,PO2-).
The presence of further coordinating donors in the molecules may modify the metal-binding
abilities of these ligands. When an acetate function is attached to a simple e-
aminophosphonate (GlyP) via the N-donor, forming an imino (N-phosphonomethyl-glycine,
Ima-mP) or nitrilo (N,N-diphosphonomethylglcine, Nma-dP) derivative, the ligands become
much stronger metal ion binders due to their tridentate or tetradentate coordination through
the formation of joint chelate systems. 12
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Figure 2. Concentration distribution curves for the complexes formed in the (a) copper(ll) 2-
aminoetanephosphonic acid (AlaP), (b) copper(ll) N-(phosphono-methyl)glycine (Ima-mP), and
(c) copper(ll)-N-di(phoshonomethyl)-glycine (Nma-dP) systems Ccu 0.002 mol dm3,
Cligand 0.004 mol dm,
This is demonstrated by the speciation diagrams of these copper(ll)-Iigand systems depicted
in Figure 2, and also reflected in the pM values (negative logarithm of the free metal ion
concentration) calculated for physiological pH at mM concentration and at a metal ion to
ligand ratio of 1:5, which are as follows’ 8.1 for Cu(ll)- AlaP, 10.2 for Cu(ll)- Ima-mP, 13.5
for Cu(ll)- Nma-dP, 10.5 for Cu(ll)-Ida and 11.6 for Cu(ll)-Nta. N-phosphonomethylglycine
or glyphosate is a popular preemergence herbicide. Besides of its direct action on
enolpyruvylshikimate-3-phosphate synthase another postulated mechanism of its action may
be the complexation of essential metal ions in plant tissues. It should be mentioned that these
mixed carboxylate-phosphonate derivatives are generally less effective metal binders than
their pure carboxylate counterparts in the acidic pH range (see Figure 2) for the above
mentioned reasons’ the larger space requirement and higher charge of the PO32- group(s).
However, there is no significant difference in their metal binding ability in the physiological
pH range (cf. pM values of the respective analogues).
When an extra carboxylate function is attached to the e-aminophosphonate molecule via
the carbon chain, as in the phosphonic derivatives of aspartic acid (Asp) and glutamic acid
(Glu), the ligands display typical ambidentate (aminocarboxylate and aminophosphonate)
coordinating capability towards transition metal ions. The coordination mode of the ligands
will be governed primarily by the relative stability sequence of the (NH2,PO32-) and
(NH2,CO2-) chelates of different ring size (see above). For instance, for the two possible
phosphono analogues of Asp (obtained either by substitution of its e- or/Y-carboxylic moiety
by a phosphonic group), it was found that aminocarboxylate and aminophosphonate
coordination can occur simultaneously. This results in the coexistence of different binding
isomers in solution (see Figure 3). This behaviour was more marked for the analogue in which
the e-carboxylate moiety was replaced by a phosphonate group. 13 This is in good accordance
with the above mentioned stability trend versus bonding mode and chelate ring size of the
complexes.
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Figure 3. Binding isomers of the bis complex CuA2 formed in the copper(ll)- Asp-uP system.
As mentioned earlier, aminophosphonic acids are potent inhibitors of many enzymes, mostly
those involved in metabolism of amino acids. A good example is the interaction of the
phosphonic analogues of 3,4-dihydroxyphenylalanine (Dopa) with tyrosinase, an enzyme
containing four copper ions bound in the active site. A comparative study of the complex-
forming properties of Dopa, DopaP [1-amino-l-(3’,4’-dihydroxyphenyl)ethylphosphonic
acid], and the phosphonic derivatives of 3,4-dihydroxyphenylglycine [1-amino-l-(3’,4’-
dihydroxyphenyl)methylphosphonic acid, DopgP] (see Figure 4) with copper(ll) revealed a
significant similarity in the metal-binding abilities of these ligands.
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Figure 4. Structural formulas of some catechol derivatives.
As can be seen in Figure 4, all these ligands contain two separated chelating functions" the
aminocarboxylate/aminophosphonate side-chain donors and the catecholate-O,O donors on
the aromatic moiety. Speciation diagrams of Dopa and DopaP with copper(ll) (see Figure 5),
demonstrate that these ligands coordinate via the side-chain donors at lower pH, but via the
catecholate function at higher pH. Of course, there is a possibility of the simultaneous ligand
coordination via both binding sites in the case of a ligand excess and of simultaneous metal
ion coordination to both binding sites in the case of a metal excess. Such type of monomeric
and oligomeric species involving mixed bonding mode are formed in the intermediate pH
range. The only significant difference due to the pO32-/CO2 substitution is that the
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formation of the oligomeric species of mixed bonding mode is less favoured with the
aminophosphonate analogue (it can be detected by EPR only in equimolar solution).Thus, it
is not surprising that DopaP serves as a synthetic substrate for tyrosinase and it does not
differentiate between the carboxylate and phosphonic functions. A marked change in activity
was achieved, by shortening the side chain by one methylene group, and the phosphonic
derivative of Dopg proved to be one of the most powerful known inhibitors of this enzyme.
However, DopgP does not display a very different metal-binding ability towards copper(ll) (see
Figure 5), although the EPR parameters suggest tetramer formation for both phosphonic
derivative instead of a dimer, what was proposed for Dopa.
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Figure 5. Concentration distribution curves for the complexes formed in the (a) copper(ll)- L-
Dopa, (b) copper(ll)-L-DopaP, and (c) copper(ll)-DopgP systems, Ccu 0.002 mol dm"3,
Cligand 0.004 mol dm.
In the cyclic dimer, the magnetic coupling between the copper(ll) centres is strong enough
to cause a seven-line splitting of the EPR signal, while in a cyclic tetramer, as found in the
copper(ll)-adrenaline system, the weaker copper(ll)-copper(ll)interaction results in a broad,
poorly-resolved signal (see Figure 6).
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Figure 6. EPR spectra of the copper(ll) -L-Dopa, -L-adrenaline,
at 1"1 metal ion ligand ratio, pH ca. 7.0, anf 77K.
L-DopaP, DopgP systems
Formation of a larger ring with DopaP and DopgP can again be explained by steric and
electrostatic reasons due to the larger space requirement and higher charge of the
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phosphonate groups. To understand the dramatic difference in behaviour of the two
phosphonate derivatives we can assume, that both substrate (Dopa and DopaP) and inhibitor
(DopgP) molecules coordinate to the active centre of tyrosinase via the catecholate binding
site with similar strengths, but the differences in charge and steric conditions of the side-
chain moiety, which is capable of strong electrostatic binding to the appropriate portion of
the enzyme, seems to be the decisive factor in the enzyme-regulatory effect. The phosphonic
acid analogue of Dopg most probably acts as a suicide inhibitor. Namely, the enzyme
catalyzes its oxidation and the radical intermediate formed exhibits inhibitory action. It is
worthwhile to mention that L-Dopa is a widely used prodrug in the treatment of Parkinson
disease. 15 In brain it undergoes decarboxylation yielding dopamine, which then acts as
neurotransmitter in substantia nigra. For therapeutic use L-Dopa must be administered in high
daily dose, as a considerable portion of this prodrug is decarboxylated in the peripheral
regions, and does not reach the brain. To avoid this extracerebral decarboxylation, L-Dopa
is generally used in combination with suitable peripheral L-Dopa decarboxylase inhibitors. 16
It would be interesting to test whether DopaP or some other phosphonic derivative of Dopa
can act as a blocker of this enzyme.
Aminopolyphosphonates as multidentate complexing agents with high specificity for various
cations are widely used for various purposes. They are applied among others in analytical
chemistry, in the paper and textile industries for the removal of trace amounts of metal ions
from bleaching baths, and also in medicine for the removal of a metal overload from living
organisms. 1723 A few important representatives of this ligand group can be seen in Figure
7, and their stability constants with several metal ions are listed in Tables II-IV.
The successive protonation constants cannot provide definite information on the protonation
sites of the particular species involved in each step. The microscopic constants, obtained
mainly via NMR techniques, unambiguously prove that the relative basicity sequence of the
donor groups (see above) is overridden by electrostatic factors. A rather complex cyclic
configuration between the protons bridging the phosphonate groups and the nitrilo group(s)
favourably reduces the repulsive forces between the negatively charged moieties. In some
cases, this results in the full protonation of the nitrogens at a lower pH than with the
corresponding amino-carboxylates.
These multidentate ligands typically form MA complexes, although molecules of lower
denticity (e.g. imino derivatives) can also form bis complexes. Complexes with tri- and
tetravalent metal ions may undergo hydrolysis and then olation at higher pH.5’22’23
A comparison of the complexing properties of mixed phosphonate and carboxylate ligands
(see Table II) indicates that the stability of the complexes increases with the number of
phosphonate moieties. In order to demonstrate this, the stabilities of various metal complexes
of Nta and its mixed phosphono derivatives are plotted against the number of substituted
phosphonate groups in Figure 8. The stability increase is seen to be much lower than would
be expected from the increase in basicity of the potentially coordinating groups: the more
carboxylate is replaced by phosphonate, the higher the electrostatic and steric hindrance that
compensate or overcompensate the former effect. 23 Metal ions such as Mg2+, Ca2 + and
Fe3 +, which have a higher affinity toward O-donors, display only slight dependences, much
less than those which favour both N- and O-coordination. The mutual repulsion between the
binegative phosphonate groups tends to lower the coordinating ability and possibly also the
denticity of the aminophosphonates with respect to their carboxylate analogues, which
results in only a slightly higher, or sometimes even lower, stability of the phosphono
complexes of the former metal ions (see Table II).
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Figure 7. Structural formulas of several open-chain and cyclic polyaminopolycarboxylic acids
and their phosphonic and phosphinic analogues.
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Table II. Log BMA values8 for some mixed carboxylic/phosphonic derivatives of nitrilotriacetic
acid (Nta)b
Metal Nta Nda-mP Nma-dP NtP
ZpK 14.1 20.6 26.2 32.8
Mg(ll) 5.50 6.28 7.20
Ca(ll) 6.44 7.18 6.17 7.50
Cu(ll) 13.1 14.08 14.67 17.40
Zn(ll) 10.66 11.55 13.48 16.37
Fe(lll) 11.8 14.65 14.60
Values are obtained from Ref. 19, 23, 32.
Structural formulas of the ligands are shown in Figure 7. Nda-mP: Nitrilobisacetic-
(methylenephosphonic) acid; Nma-dP: Nitriloacetic-bis(methylenephosphonic acid); NtP:
nitrilotris(methylenephosphonic acid).
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Figure 8. log/MA values for metal complexes of mixed phosphonic-carboxylic derivatives of
Nta, N(CH2PO3H2)n(CH2COOH)3_n.
When the coordinating abilities of the bi- and trinegatively charged metal ions are compared,
it is seen that the larger positive charge on Fe3 + does not reduce significantly the repulsion
of the negative phosphonate groups. The reason for this is not clear. It is also seen that the
stabilities of the Fe(lll) complexes of bis- and trisphosphono derivatives are about the same,
which suggests a decrease in denticity of the latter ligand in its complexes.
The high stability of metal complexes of polyaminopolyphosphonates can be utilized in the
chelation therapy of metal overload diseases. For instance, the only available treatment of an
iron overload resulting from thalassaemia is drug therapy with chelating agents.
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Thalassaemias are characterized by various genetically determined defects of globin chain
synthesis. The only way to treat the disease-associated anaemia is by regular and frequent
blood transfusion. The non-elimination of blood iron and the hyperabsorption of iron from the
diet can lead to the accumulation of an enormous amount of iron, which, during long-term
treatment, can attain a level of 40-100 g.24 In order to mobilize the iron the desferrioxamine
B (Dfo) of natural origin proved to be very efficient, but the major limitation to its use was
its low effectiveness when administered orally and also its rather high cost. In the search for
an ideal iron chelator, large number of multidentate ligands have been studied. For example,
Ehpg (N,N’-ethylenbis-[2-(o-hydroxyphenyl)methylglycine]) and Hbed (N,N’-di(2-hydroxy-
benzyl)-ethylenediamine-N,N’diacetic acid) as well as their phosphono derivatives (some of
them are depicted in Figure 7) have been reported2123 to form high-stability chelates, due
to the high affinity of Fe(lll) for the phenolate groups and to the orientation of these groups
to form joint chelate systems including the amino and carboxylate/phosphonate functions.
The stability constants of the main 1’1 species, formed exclusively at physiological pH in
these metal-ligand systems are listed in Table II1. Besides the data for Fe(lll) and Cu(ll)
complexes, those for Ga(lll) and In(Ill) are also included in the Table because of their potential
applicability as radiopharmaceuticals.
Table II1. Log ]MA values for some phosphonic and phosphinic derivatives of N,N’-ethylenbis-
[2-(o-hydroxyphenyl)glycine] (Ehpg)a
Metal Ehpg EhpgP EhpgPi Hbed HbedP HbedPMe HbedPEt Pied
’pK 37.0 46.0 34.0 41.0 51.0 37.0 37.0 50.0
Fe(lll) 33.9b 25.0d 31.25c 39.68e prec 28.21 e 28.19 36.91 b
Ga(lll) 33.65 39.570 28.030 27.98 36.355
In(Ill) 33.0b 39.660 28.12 28.09 36.89b
Cu(ll) 23.94b 18.58d 20.14e 23.69 24.00 23.04 23.01 19.915
a Structural formulas of the ligands are shown in Figure 7. Ehpg, N,N’-ethylenbis-[2-(o-
hydroxyphenyl)glycine]; EhpgP, N,N’-ethylenbis-[2-(o-hydroxyphenyl)methylenephosphonic
acid]; EhpgPi, N,N’-ethylenbis-[2-(o-hydroxyphenyl)methylenephosphinic acid]; Hbed, N,N’-
di(2-hydroxybenzyl)ethylenediamine-N,N’-diacetic acid; HbedP, N,N’-di(2-hydroxybenzyl)-
ethylenediamine-N,N’-(bismeth1enephosphonic acid); HbedPMe, N,N’-di(2-hydroxybenzyl)-
ethylene-diamine-N,N’-(bismethylenephosphonic acid monomethyl ester); HbedPEt, N,N’-di(2-
hydroxybenzyl)ethylenediamine-N,N’-(bismethylenephosphonic acid monoethyl ester); Pied,
N,N’-dipyridoxylethylenediamine-N,N’-diacetic acid;
b see Ref. 45, c see Ref. 28, d see Ref. 46, o see Ref. 5.
A comparison of the stability constants of the MA complexes shows that phosphonic
derivatives form less stable chelates than the analogous aminocarboxylates, even if the
overall basicity of the coordinating donors is higher. The complexes, however, are still very
stable and formed practically quantitatively at the physiological pH range (pM values are never
lower than 25 in solution of mM metal ion and 5 mM ligand at pH 7.4). The reason for the
somewhat less favoured formation of phosphono complexes is again the large mutual charge
repulsion between the binegative phosphonate groups when more than one such group is
coordinated to the same metal ion. In principle, these ligands are typical ambidentate
molecules able to form complexes through coordination of the amino and phosphonate/
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carboxylate groups or the amino and phenolate groups, or with the simultaneous participation
of all six donors. Accordingly, with copper(ll) and other bivalent transition metal ions complex
formation takes place in two more or less separated steps,z2 In the first, in the acidic pH
range, diprotonated complexes CuH2A are formed containing three joint chelate rings with
protonated non-coordinated phenolic-OH groups. With increasing pH, the metal ion begins to
compete successfully with the proton for the phenolate groups, and the fully deprotonated
complex MA is formed. In CuA, there is probably strong coordination of the metal ion with
the amino nitrogens and phenolate oxygens in approximately co-.planar positions and weaker
coordination with the phosphonate or carboxylate oxygens in the fifth and sixth positions
above and below the plane, as clearly indicated by the occurrence of a phenolate O
M charge-transfer band at around 400 nm.z2 It is a general tendency that polyamino-
polyphosphono derivatives form protonated complexes more readily, sometimes with similar
stability to those of the parent complexes; this strongly suggests that protonation occurs on
the non-coordinated phosphonic moieties. This situation is different from that for the
aminocarboxylate analogues, where all donor groups are generally coordinated to the metal
ion, and thus protonation takes place through proton displacement of the metal ion from the
most basic nitrogen site, resulting in a significant decrease in the stability of the protonated
complexes. In contrast, with trivalent metal ions all protons from the ligands are displaced in
a single step and thus protonated complexes are hardly formed. Complexes with
aminopolyphosphinates are generally less stable than both the carboxylate and phosphonate
analogues, although partial coordination of the phosphinic groups is supported by both the
stability and the spectral data. 1’2629 Incomplete participation of the donor sites in metal
binding, however, as was demostrated for many of the metal-phosphono complexes, may
make these ligands more selective for cations with an enhanced capacity for coordination.
Because of the high stabilities of the complexes and the fulfilment of the required selectivity
at physiological pH, organophosphonates may be promising candidates for the treatment of
iron overload anaemias,s
The equilibrium, structural and kinetic behaviour of metal complexes of cyclic
polyaminopolyphosphonates differs considerably from those of their open-chain counterparts.
A few interesting and well-studied representatives of this group are shown in Figure 7. As
concerns the acid-base chemistry of these ligands, the cyclic structure modifies the normal
basicity sequence (amino being more basic basic than phosphonate) of the donor groups. The
protonation equilibria of the aza-N and phosphonate-O donors more or less overlap each
other.3O,31 This is fairly well seen in the series of triaza- and tetraazaalicyclicphosphonic acids
in which the most basic sites are two ring nitrogens while phosphonate oxygens are less
basic and are protonated todifferent degrees depending on the ring structure. In the tetraaza
ligand the protonation of the pendant phosphonate oxygens is more extensive than that in
the triaza ligand, before further protonation of the ring nitrogen occurs.3 The stabilities of
some biologically important metal complexes of several triaza- and tetraazaphosphonic
derivatives and their carboxylic analogues are shown in Table IV. It can be seen from these
data that, besides the basicity of the coordinating donors, as is the case for the open-chain
polyaminopolyphosphonates, the size of the ring comprising the metal ion is the main factor
governing the metal-binding ability. This is clearly indicated by the fairly high complexation
selectivity of the larger Ca2 + ion over the smaller Mg2 + ion with all tetraaza derivatives and
by a reverse selectivity with the triazaalicyclic compounds. Bivalent transition metal ions form
considerably more stable complexes due to their greater ability to form metal-nitrogen
bonds, than the more ionic alkaline earth metal ions.
259Volume 1, Nos. 2-3, 1994 Chelating Tendencies ofBioactive Aminophosphonates
Table IV. Log JMA valuesa for some aminocarboxylate, -phosphinate and -phosphonate
complexes
Ligandb ’pK Mg(ll) Ca(ll) Sr(ll) Cu(ll) Zn(ll) Cd(ll) Gd(lll)
Nota 22.0 9.7 8.9 18.3 16.0 14.4
NotP 35.4 11.0 6.4 21.3 24.9 19.7
NotPmE 16.9 6.2 5.1 1 5.8 13.4 10.3
Dota 30.0 11.0 15.9 12.8 19.1 18.9 19.1
DotP 43.0 7.3 10.3 9.8 22.9 24.8
DotPi 22.9 4.4 9.4 8.9 19.6 15.8 16.7
DotPmE 22.1 4.6 9.1 8.9 14.6
DotPmB 21.4 4.3 8.5 8.1 14.8 18.6
24.6
16.5
16.5
12.5
a Values are obtained from Ref. 47-49.
b Structural formulas of the ligands are shown in Figure 7. Nota, 1,4,7-triazacyclononane-
triacetic acid; NotP, 1,4,7-triazacyclononanetris(methylenephosphonic acid); NotPmE, 1,4,7-
triazacyclononanetris(methylenephosphonic acid monomethyl ester) Dota, 1,4,7,10-tetra-
azacyclododecanetetraacetic acid; DotP, 1,4,7,10-tetraazacyclododecanetetrakis-
(methylenephosphonic acid); DotPi, 1,4,7,10-tetraazacyclododecanetetrakis(methylene-
phosphinic acid); DotPmE, 1,4,7,10-tetraazacyclo-dodecanetetrakis(methylenephosphonic
acid monomethyl ester); DotPmB, 1,4,7,10-tetraazacyclododecanetetrakis(methylene-
phosphonic acid monobuthyl ester).
A comparison of the stability constants of phosphonic derivatives with those of the tetraaza-
ring, cyclen (log KCaA=3.1, log KZnA 16.21, log KCdA 14.3 and log KcuA =24.8),32
indicates that the side-chain donors contribute substantially to the stability of the earth metal
complexes, and only slightly to that of the transition metal complexes. Thus, those metal ions
which prefer oxygen coordination are strongly stabilized by the presence of the side-chain O
donors, while the stabilities of the transition metal complexes are basically determined by the
coordination of the ring nitrogens. All phosphonate derivatives form less stable complexes
than do the analogous carboxylates. Although structural data are not available, it is
reasonable to assume that P032-/C02 substitution decreases the denticity of coordination,
especially to alkaline earth cations, which is manifested in the lower stability of the
phosphonates, even if their overall basicity is higher. Macrocyclic aminophosphonates exhibit
a much stronger tendency to form oligomeric complexes than the analogous carboxylic
compounds.This phenomenon can be easily explained by the steric and electrostatic repulsion
between the phosphonate groups. Formation of oligomeric species keeps the bridging
binegative phosphonate arms far away from each other minimizing these effects.
Besides the high stability, kinetic inertness makes these macrocyclic complexes particularly
suitable for medical applications, for instance in radioimmune therapy333s and magnetic
resonance tomography.7’39’4 In both fields, certain metal ions (such as In3 +, Tc3 +, Cu2 +,
y3 +, Au3 +, Gd3 +) are used in the form of stable complexes of organic ligands either, to bind
the metal ions to monoclonal antibody in radioimmun therapy or to decrease their toxicity in
NMR tomography. The most popular complex forming agents are open-chain
polyaminopolycarboxylates, which are now being increasingly replaced by their macrocyclic
analogues, which offer much higher thermodynamic and kinetic stability for the metal
complexes. In NMR tomography, Gd3 + complexes, having strong paramagnetic properties,
are widely used to enhance the contrast of NMR images. Besides the complexes Gd(Dtpa)2-
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and Gd(Dota)-, which are now approved contrast agents in clinical therapy, intensive
research is under way in many laboratories to prepare new derivatives. Phosphonic analogues
can be useful in order to improve their applicability, especially in two aspects: to prepare (a)
neutral and (b) tissue-specific complexes. The Gd3+ complexes of the various tetraaza-
phosphonic derivatives, although are less stable than those of the carboxylate analogue
DOTA, they are able to bind Gd3 + strongly enough to ensure the fast and complete excretion
of this toxic metal ion in a reasonably short time after administration. The distribution of some
S3Sm(lll)-tetraaza derivatives in the various body tissues 30 minutes after administration is
shown in Figure 9.41 The metal binding ability of Sm(lll) is very similar to that of Gd(lll), and
the use of S3Sm makes its detection easy.
% Inlecled dose 30.13130
(after 30 mln)
Figure 9. Distribution of several S3Sm(lll) complexes in body tissues and fluids of rat 30
minutes after administration.
It can be seen that 153Sm(Dtpa)2- concentrates mainly in the muscles and the blood, while
153Sm(DotPmE)- and 153Sm(DotPmB)- are found in the blood and the small intestines,
respectively. The corresponding Gd(lll) complexes have quite similar biodistribution
characteristics in rats. Gd(DotPmB)- in association with serum albumin shows significantly
increased relaxivity, resulting in higher sensitivity than that of any other Gd(lll) complex. It
is completely excreted from the body through the hepato-biliary system. In vivo MRI studies
of the Gd(DotPmE)- and Gd(DotPmB)- in rabbits exhibited remarkable specificity for liver
tissues. Thus, these ligands seem to be most promising candidates for further trials.
Another possible biological importance of these ligands lays in their potential application
for measurement of level of certain cations in cells and tissues. Because of the significant
selectivity among alkaline earth metal ions (see Table IV), triaza derivatives might be suitable
to measure the free Mg2 + level, while tetraaza derivatives can be used to measure the free
Ca2+ concentration in biological systems. Their slow ligand exchange reactions may result
in different 31p NMR signals for the free and metal ion bound species. It was found42 for
example, as shown in Figure 10, that the triazaphosphonic acid ester NOTPmE gave two well-
separated lp resonances in human red blood cells, corresponding to free and Mg2+-bound
NotPmE.
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Mg2.
20 0 -20 ppm
Figure 10. 31p NMR spectra of NotPmE loaded red blood cells.
Reasonable quantitative concentration values could be calculated by peak integration.
Because of the significant selectivity of NotPmE for Mg2 + over Ca2 + at physiological pH, the
Mg2+ level could be monitored without interference from Ca2+ In principle, tetraaza
derivatives, showing a reversed Ca2+- Mg2 + selectivity (see Table IV), may be applicable
to measure the Ca2 + level in biological tissues. Such studies are also now in progress.
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